Clinical Trial Update: Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating interferon and lovastatin for malignant melanoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Interferon (interferon)
• Lovastatin (Lovastatin)

Snippet

Sponsor: NeoPlas Innovation | Conditions: Melanoma, Malignant Melanoma | Phase 2 | Status: WITHDRAWN